Septic shock affects more than 230,000 U.S. patients each year, but JAMA has published new advances in diagnosing and treating this clinical emergency in hopes of reducing that number.
Here are three updates in septic shock care.
1. To recognize complicating factors such as hypovolemia or cardiogenic shock in patient, the JAMA article authors recommend focused ultrasonography. Invasive hemodynamic monitoring is recommended only for select patients.
2. In septic shock, three randomized clinical trials have demonstrated that protocolized care offers little advantage compared to management without a protocol.
3. Hydroxyethyl starch is no longer recommended for septic shock patients, and debate continues about the role of various crystalloid solutions and albumin.
To read the full report, click here.
More articles on sepsis and septic shock:
New algorithm can help detect sepsis earlier
6 strategies to improve early sepsis recognition
Wolters Kluwer Health piloting app to fight sepsis